News

Dr. Onyinye I. Iweala discusses a recently published review that provided updated recommendations for ordering tryptase tests ...
OHSU researcher treats patients with rare and debilitating skin conditions Alex Ortega Loayza, M.D., M.C.R., interim chair ...
A new snakebite treatment combines an existing drug with antibodies from a hyperimmune reptile collector, raising both hopes ...
BBC's Doctor Xand has said that some people are doing food intolerance tests as they believe that what they are eating and ...
Among patients with triple-negative breast cancer, the Naples prognostic score predicted survival outcomes more accurately ...
Nuravax Inc., a biotechnology company pioneering immunotherapy for neurodegenerative disorders, has been awarded a $3 million ...
The Cozzarelli Prize recognises publications that reflect scientific excellence and originality. The 2024 prize for the best ...
BUFFALO, N.Y. – The University at Buffalo School of Nursing has opened its first wet laboratory, a milestone that expands the ...
The global in vitro diagnostics (IVD) market has exhibited significant growth, with its valuation rising from $67,111 million in 2019 to an estimated $91,093 million by 2027. This ...
Welcome to the Adaptive Biotechnologies first-quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...
The research, published in Cell, describes how two of Friede’s antibodies were combined with varespladib, a drug known to block venom enzymes that harm nerves and muscles. The resulting treatment ...
Published in Nature Immunology ... tools to analyze thousands of proteins in their blood plasma and linked these findings to ...